# Horizon Technology Finance Corp: financial statements, quarterly

HRZN · Nasdaq · CIK 1487428 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hrzn.md) · [Financials](/companies/hrzn/financials.md) · [Filings](/companies/hrzn/filings.md) · [Insiders](/companies/hrzn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hrzn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [7.1](/filings/0001437749-24-032485.md) | [7.6 d](/filings/0001437749-26-006636.md) | [8.2](/filings/0001437749-25-013547.md) | [7.9](/filings/0001437749-25-025497.md) | [7.9](/filings/0001437749-25-031988.md) | [8.2 d](/filings/0001437749-26-006636.md) | [8.7](/filings/0001437749-26-014916.md) | [8.2](/filings/0001437749-26-025689.md) | [7.9](/filings/0001437749-25-031988.md) | [8.0 d](/filings/0001437749-26-006636.md) | [8.2](/filings/0001437749-26-014916.md) | [7.8](/filings/0001437749-26-025689.md) |
| Net income | $m | [(12.0)](/filings/0001437749-24-032485.md) | [(10.7) d](/filings/0001437749-26-006636.md) | [8.7](/filings/0001437749-25-013547.md) | [(9.1)](/filings/0001437749-25-025497.md) | [7.3](/filings/0001437749-25-031988.md) | [(12.4) d](/filings/0001437749-26-006636.md) | [(21.4)](/filings/0001437749-26-014916.md) | [(20.8)](/filings/0001437749-26-025689.md) | [30.7](/filings/0001437749-25-031988.md) | [8.8 d](/filings/0001437749-26-006636.md) | [2.8](/filings/0001437749-26-014916.md) | [(37.3)](/filings/0001437749-26-025689.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.26](/filings/0001437749-25-013547.md) | [(0.26)](/filings/0001437749-25-025497.md) | [0.20](/filings/0001437749-25-031988.md) | not reported | [(0.53)](/filings/0001437749-26-014916.md) | [(0.50)](/filings/0001437749-26-025689.md) | [0.68](/filings/0001437749-25-031988.md) | not reported | [0.06](/filings/0001437749-26-014916.md) | [(0.57)](/filings/0001437749-26-025689.md) |
| Basic EPS | $ per share | [0.53](/filings/0001437749-24-032485.md) | not reported | [0.26](/filings/0001437749-25-013547.md) | [(0.26)](/filings/0001437749-25-025497.md) | [0.20](/filings/0001437749-25-031988.md) | not reported | [(0.53)](/filings/0001437749-26-014916.md) | [(0.50)](/filings/0001437749-26-025689.md) | [0.71](/filings/0001437749-25-031988.md) | not reported | [0.06](/filings/0001437749-26-014916.md) | [(0.57)](/filings/0001437749-26-025689.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [34.8](/filings/0001437749-24-032485.md) | [46.6](/filings/0001437749-26-006636.md) | [46.9](/filings/0001437749-25-013547.md) | [81.3](/filings/0001437749-25-025497.md) | [52.3](/filings/0001437749-25-031988.md) | [70.3](/filings/0001437749-26-006636.md) | [33.0](/filings/0001437749-26-014916.md) | [24.7](/filings/0001437749-26-025689.md) | [84.7](/filings/0001437749-25-031988.md) | [106](/filings/0001437749-26-025689.md) | [34.5](/filings/0001437749-26-014916.md) | [75.0](/filings/0001437749-26-025689.md) |
| Total assets | $m | [797](/filings/0001437749-23-029551.md) | [802](/filings/0001437749-25-006114.md) | [802](/filings/0001437749-24-013992.md) | [787](/filings/0001437749-24-023921.md) | [793](/filings/0001437749-24-032485.md) | [822](/filings/0001437749-26-006636.md) | [790](/filings/0001437749-25-013547.md) | [727](/filings/0001437749-25-025497.md) | [759](/filings/0001437749-25-031988.md) | [811](/filings/0001437749-26-025689.md) | [792](/filings/0001437749-26-014916.md) | [832](/filings/0001437749-26-025689.md) |
| Total liabilities | $m | [451](/filings/0001437749-23-029551.md) | [478](/filings/0001437749-25-006114.md) | [470](/filings/0001437749-24-013992.md) | [459](/filings/0001437749-24-023921.md) | [451](/filings/0001437749-24-032485.md) | [486](/filings/0001437749-26-006636.md) | [484](/filings/0001437749-25-013547.md) | [443](/filings/0001437749-25-025497.md) | [444](/filings/0001437749-25-031988.md) | [493](/filings/0001437749-26-025689.md) | [458](/filings/0001437749-26-014916.md) | [415](/filings/0001437749-26-025689.md) |
| Long-term debt | $m | [436](/filings/0001437749-23-029551.md) | [462](/filings/0001437749-25-006114.md) | [452](/filings/0001437749-24-013992.md) | [443](/filings/0001437749-24-023921.md) | [434](/filings/0001437749-24-032485.md) | [468](/filings/0001437749-26-006636.md) | [467](/filings/0001437749-25-013547.md) | [425](/filings/0001437749-25-025497.md) | [424](/filings/0001437749-25-031988.md) | [473](/filings/0001437749-26-025689.md) | [447](/filings/0001437749-26-014916.md) | [402](/filings/0001437749-26-025689.md) |
| Shareholders' equity | $m | not reported | [324](/filings/0001437749-26-006636.md) | [332](/filings/0001437749-25-025497.md) | [329](/filings/0001437749-25-031988.md) | [343](/filings/0001437749-25-031988.md) | [336](/filings/0001437749-26-025689.md) | [305](/filings/0001437749-26-025689.md) | [284](/filings/0001437749-26-025689.md) | [316](/filings/0001437749-25-031988.md) | [319](/filings/0001437749-26-025689.md) | [334](/filings/0001437749-26-025689.md) | [418](/filings/0001437749-26-025689.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(23.7) d](/filings/0001437749-24-032485.md) | [11.2 d](/filings/0001437749-26-006636.md) | [4.0](/filings/0001437749-25-013547.md) | [54.3 d](/filings/0001437749-25-025497.md) | [(28.3) d](/filings/0001437749-25-031988.md) | [(26.1) d](/filings/0001437749-26-006636.md) | [(13.2)](/filings/0001437749-26-014916.md) | [49.6 d](/filings/0001437749-26-025689.md) | [50.6 d](/filings/0001437749-25-031988.md) | [(30.4) d](/filings/0001437749-26-006636.md) | [(42.1)](/filings/0001437749-26-014916.md) | [124 d](/filings/0001437749-26-025689.md) |
| Dividends paid | $m | [10.3 d](/filings/0001437749-24-032485.md) | [12.0 d](/filings/0001437749-26-006636.md) | [10.4](/filings/0001437749-25-013547.md) | [12.6 d](/filings/0001437749-25-025497.md) | [11.4 d](/filings/0001437749-25-031988.md) | [12.1 d](/filings/0001437749-26-006636.md) | [12.7](/filings/0001437749-26-014916.md) | [12.9 d](/filings/0001437749-26-025689.md) | [13.5 d](/filings/0001437749-25-031988.md) | [14.0 d](/filings/0001437749-26-006636.md) | [14.7](/filings/0001437749-26-014916.md) | [10.6 d](/filings/0001437749-26-025689.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [33.6](/filings/0001437749-25-013547.md) | [35.4](/filings/0001437749-25-025497.md) | [36.6](/filings/0001437749-25-031988.md) | [40.2](/filings/0001437749-26-014916.md) | [41.2](/filings/0001437749-26-025689.md) | [45.8](/filings/0001437749-25-031988.md) | [47.3](/filings/0001437749-26-014916.md) | [65.0](/filings/0001437749-26-025689.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 67,033,909 at 2026-08-04, from the cover of the [10-Q filed 2026-08-04](/filings/0001437749-26-025689.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.